In addition, the characteristic elevated NADH level of cancer cells makes it possible for CTBP1 to bind to NADP with a high affinity, thus triggering a conformational change that leads to hyper-activity of both tumorigenesis and tumor progression. The gene discussed is CTBP1; the disease is cancer.